During the past recent years, various therapies emerged in the era of breast cancer. Breast
cancer is a heterogeneous disease in which genetic and environmental factors are involved …

Breast cancer is the most prevalent cancer among women worldwide. However, increased
survival is due to the dramatic advances in the screening methods, early diagnosis, and …

Breast cancer is the second leading cause of death for women worldwide. The
heterogeneity of this disease presents a big challenge in its therapeutic management …

Breast cancer (BC) is one of the prevalent cancers among women. Generally, the treatment
of BC is mostly based on several prominent strategies, including chemotherapy, surgery …

Breast cancer is the most commonly diagnosed cancer type and the leading cause of cancer-
related mortality in women worldwide. Breast cancer is fairly heterogeneous and reveals six …

Breast cancer (BC) is one of the most widely diagnosed cancers and a leading cause of
cancer death among women worldwide. Globally, BC is the second most frequent cancer …

Antibody drug conjugates (ADCs) are novel medications that combine monoclonal
antibodies with cytotoxic payloads, enabling the selective delivery of potent drugs to cancer …

Breast cancer is categorized at the molecular level according to the status of certain
hormone and growth factor receptors, and this classification forms the basis of current …

Breast cancer is the most common invasive tumor in women and the second leading cause
of cancer-related death. Nanomedicine raises high expectations for millions of patients as it …

Breast cancer is a major cause of suffering and mortality among women. Limitations in the
current diagnostic methods and treatment approaches have led to new strategies to …